Precision medicine for metastatic colorectal cancer: an evolving era-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Precision medicine for metastatic colorectal cancer: an evolving era

Published:2019-09-03 Issue:10 Volume:13 Page:919-931
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Guler Irem¹^ORCID,Askan Gokce²^ORCID,Klostergaard Jim³^ORCID,Sahin Ibrahim Halil⁴^ORCID

Affiliation:

1. Department of Medicine, Baskent University School of Medicine, Ankara, Turkey

2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

3. Department of Molecular and Cellular Oncology, MD Anderson Cancer Center, Houston, TX, USA

4. Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2019.1663174

Reference108 articles.

1. Colorectal cancer statistics, 2017

2. The distinctive biology of cancer in adolescents and young adults

3. Cancer screening in the United States, 2018: A review of current American Cancer Society guidelines and current issues in cancer screening

4. Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

5. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue Elasticity as a Diagnostic Marker of Molecular Mutations in Morphologically Heterogeneous Colorectal Cancer;International Journal of Molecular Sciences;2024-05-14

2. Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine;JCO Oncology Practice;2024-05-13

3. Construction and validation of “WCH‐nomogram” for predicting the prognosis after resection of colorectal liver metastases;Cancer Medicine;2024-05

4. Immunotherapy in pMMR/MSS Metastatic Colorectal Cancer;Nature Cell and Science;2024-03-30

5. Characterization of dabrafenib-induced drug insensitivity via cellular barcoding and collateral sensitivity to second-line therapeutics;Scientific Reports;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3